Working Groups

Active?
Facet Toggle

A New Grand Bargain to Improve the Antimicrobial Market for Human Health
Amanda Glassman
et al.
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
Incorporating Economics and Modelling in Global Health Goals and Guidelines
Amanda Glassman
et al.
November 15, 2017
International organizations influence national-level health sector priorities by affecting how much funding is available for healthcare delivery within countries and setting limits on how that funding is used. They exert particular influence in setting disease-specific targets, developing clinical g...
Working Group on the Future of Global Health Procurement
Amanda Glassman
et al.
July 31, 2017
Many low-and lower-middle-income countries currently procure a large portion of their health commodities through centralized, donor-managed procurement mechanisms, and often at subsidized prices or as donations. Over the next several decades, however, the landscape of global health procurement will ...
Next Generation Financing Models in Global Health
Amanda Glassman
et al.
August 19, 2015
Improving Migration Data (May 2008–May 2009)
Devesh Kapur
et al.
September 11, 2014
Priority-Setting Institutions for Global Health
Amanda Glassman
and
Kalipso Chalkidou
September 10, 2014
If you have $200 to spend on health in a developing country, would you vaccinate 10 children against deadly childhood diseases or provide AIDS treatment to one woman to prevent transmission of HIV to her unborn child? Policy makers routinely face such tough budgetary dilemmas with little expert guid...